ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership8,031,921 shares
Latest Disclosed Value $ 61,616,480
Geode Capital Management, Llc reports 1.41% increase in ownership of 26CA / ImmunityBio, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 8,031,921 shares of ImmunityBio, Inc. (DE:26CA) valued at $52,689,402 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 7,920,178 shares of ImmunityBio, Inc.. This represents a change in shares of 1.41% during the quarter. The current value of the position is $49,235,676 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM 45256X103 8,031,921 111,743 1.41 61,616 292.86 0.0020
2026-02-09 2025-12-31 13F IMMUNITYBIO COM 45256X103 7,920,178 1,030,113 14.95 15,684 -7.48 0.0010
2025-11-12 2025-09-30 13F IMMUNITYBIO COM 45256X103 6,890,065 1,112,796 19.26 16,952 11.14 0.0011
2025-08-08 2025-06-30 13F IMMUNITYBIO COM 45256X103 5,777,269 1,487,849 34.69 15,254 18.12 0.0011
2025-05-13 2025-03-31 13F IMMUNITYBIO COM 45256X103 4,289,420 448,502 11.68 12,914 31.31 0.0010
2025-02-12 2024-12-31 13F IMMUNITYBIO COM 45256X103 3,840,918 -5,757 -0.15 9,835 -31.29 0.0008
2024-11-12 2024-09-30 13F IMMUNITYBIO COM 45256X103 3,846,675 -70,819 -1.81 14,312 -42.20 0.0012
2024-08-09 2024-06-30 13F IMMUNITYBIO COM 45256X103 3,917,494 436,108 12.53 24,763 32.44 0.0022
2024-05-13 2024-03-31 13F IMMUNITYBIO COM 45256X103 3,481,386 101,922 3.02 18,698 10.20 0.0017
2024-02-13 2023-12-31 13F IMMUNITYBIO COM 45256X103 3,379,464 573,281 20.43 16,967 257.71 0.0018
2023-11-13 2023-09-30 13F IMMUNITYBIO COM 45256X103 2,806,183 75,731 2.77 4,743 -37.51 0.0006
2023-08-11 2023-06-30 13F IMMUNITYBIO COM 45256X103 2,730,452 784,588 40.32 7,591 114.35 0.0009
2023-05-15 2023-03-31 13F IMMUNITYBIO COM 45256X103 1,945,864 -84,628 -4.17 3,541 35,310.00 0.0005
2023-02-13 2022-12-31 13F IMMUNITYBIO COM 45256X103 2,030,492 108,903 5.67 10 -99.90 0.0014
2022-11-14 2022-09-30 13F IMMUNITYBIO COM 45256X103 1,921,589 348,755 22.17 9,550 63.25 0.0014
2022-08-12 2022-06-30 13F IMMUNITYBIO COM 45256X103 1,572,834 24,819 1.60 5,850 -32.63 0.0009
2022-05-13 2022-03-31 13F IMMUNITYBIO COM 45256X103 1,548,015 -8,586 -0.55 8,684 -8.24 0.0011
2022-02-11 2021-12-31 13F IMMUNITYBIO COM 45256X103 1,556,601 40,345 2.66 9,464 -35.92 0.0011
2021-11-12 2021-09-30 13F IMMUNITYBIO COM 45256X103 1,516,256 46,560 3.17 14,768 -29.63 0.0020
2021-08-13 2021-06-30 13F IMMUNITYBIO COM 45256X103 1,469,696 805,147 121.16 20,987 33.03 0.0029
2021-05-12 2021-03-31 13F IMMUNITYBIO COM 45256X103 664,549 74,788 12.68 15,776 100.69 0.0024
2021-02-12 2020-12-31 13F NANTKWEST COM 63016Q102 589,761 58,015 10.91 7,861 113.21 0.0013
2020-11-13 2020-09-30 13F NANTKWEST COM 63016Q102 531,746 40,518 8.25 3,687 -38.88 0.0007
2020-08-13 2020-06-30 13F NANTKWEST COM 63016Q102 491,228 169,729 52.79 6,032 552.11 0.0013
2020-05-14 2020-03-31 13F NANTKWEST COM 63016Q102 321,499 32,865 11.39 925 -15.37 0.0002
2020-02-20 2019-12-31 13F/A-1 NANTKWEST COM 63016Q102 288,634 27,216 10.41 1,093 243.71 0.0002
2020-02-13 2019-12-31 13F NANTKWEST COM 63016Q102 288,634 27,216 1,093 139.2933
2019-11-12 2019-09-30 13F NANTKWEST COM 63016Q102 261,418 0 0.00 318 19.55 0.0001
2019-08-14 2019-06-30 13F NANTKWEST COM 63016Q102 261,418 -79,951 -23.42 266 -50.65 0.0001
2019-05-14 2019-03-31 13F NANTKWEST COM 63016Q102 341,369 12,492 3.80 539 41.47 0.0001
2019-03-06 2018-12-31 13F/A-1 NANTKWEST COM 63016Q102 328,877 8,961 2.80 381 -67.79 0.0001
2019-02-13 2018-12-31 13F NANTKWEST COM 63016Q102 328,877 8,961 381
2018-11-13 2018-09-30 13F NANTKWEST COM 63016Q102 319,916 19,809 6.60 1,183 28.87 0.0003
2018-08-14 2018-06-30 13F NANTKWEST COM 63016Q102 300,107 12,518 4.35 918 -17.89 0.0003
2018-05-15 2018-03-31 13F NANTKWEST COM 63016Q102 287,589 3,359 1.18 1,118 -12.38 0.0004
2018-02-13 2017-12-31 13F NANTKWEST COM 63016Q102 284,230 8,386 3.04 1,276 -15.55 0.0004
2017-11-14 2017-09-30 13F NANTKWEST COM 63016Q102 275,844 -15,657 -5.37 1,511 -31.69 0.0006
2017-08-14 2017-06-30 13F NANTKWEST COM 63016Q102 291,501 34,802 13.56 2,212 142.81 0.0009
2017-06-21 2017-03-31 13F/A-1 NANTKWEST COM 63016Q102 256,699 18,685 7.85 911 -33.06 0.0004
2017-05-12 2017-03-31 13F NANTKWEST COM 63016Q102 256,699 911
2017-02-14 2016-12-31 13F NANTKWEST COM 63016Q102 238,014 6,391 2.76 1,361 -24.47 0.0006
2016-11-10 2016-09-30 13F NANTKWEST COM 63016Q102 231,623 132,626 133.97 1,802 193.01 0.0009
2016-08-12 2016-06-30 13F NANTKWEST COM 63016Q102 98,997 10,632 12.03 615 -15.29 0.0003
2016-05-13 2016-03-31 13F NANTKWEST COM 63016Q102 88,365 2,998 3.51 726 -50.91 0.0004
2016-02-12 2015-12-31 13F NANTKWEST COM 63016Q102 85,367 12,439 17.06 1,479 77.13 0.0008
2015-11-13 2015-09-30 13F NANTKWEST COM 63016Q102 72,928 72,928 835 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.